Tag Archives: launch

Sanofi’s Eloctate, a Bioverativ buyout centerpiece, suffers on Roche’s Hemlibra launch

Sanofi has been among the pharma companies hardest hit by U.S. pricing pressure in diabetes, and now, competition is taking a toll on a prized asset from its $ 11.6 billion Bioverativ buyout. In the first quarter, hemophilia drug Eloctate’s sales of €174 missed consensus estimates of €204 million by 14.7%, ODDO BHF analysts wrote in… Read More »

Indivior to launch cheaper opioid addiction drug; maintains forecast

(Reuters) – British drugmaker Indivior Plc said on Tuesday it would launch a cheaper version of its blockbuster opioid addiction treatment drug, while maintaining its full-year profit and revenue forecast, sending its shares up more than 20 percent. The company is trying to hold off rivals Dr. Reddy’s Laboratories and Teva Pharmaceuticals from bringing their… Read More »

AbbVie inks Humira patent deal No. 7, delaying Pfizer's U.S. biosim launch until late 2023

AbbVie is on a hot streak striking patent deals to protect its top drug, Humira. Even as Boehringer Ingelheim has opted to fight the company’s patent claims in court, Pfizer has decided it’s in its own best interest to settle on a late 2023 biosimilar launch date. Under a licensing agreement with AbbVie, Pfizer can… Read More »